Evidence map›Paper›PMID 40486320›Full record

ArticleCureus2025

Therapeutic Insights Into a Case-Control Approach to B-cell Lymphoma 3 (BCL3)-Encoded Protein by Exploring Immune Modulation and Clinical Strategies in Oral Carcinomas.

Mostafa Ahmed Abdellah Ahmed, Lareb Asad, Madeeha Minhas, Abdul Rehman Khalil Shaikh, Seemi Tanvir, Muhmmad Hussain Shah, Aneesa Khalid

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mostafa Ahmed Abdellah AhmedGeneral Surgery, Frimley Health NHS Foundation Trust, Frimley, GBR.
Lareb AsadPathology, Peoples University of Medical and Health Sciences, Nawabshah, PAK.
Madeeha MinhasHealth Sciences, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU.
Abdul Rehman Khalil ShaikhPathology, Liaquat University of Medical and Health Sciences, Jamshoro, PAK.
Seemi TanvirPathology, Margalla Institute of Health Sciences, Rawalpindi, PAK.
Muhmmad Hussain ShahPathology, Dow University of Health Sciences, Dow International Medical College, Karachi, PAK.
Aneesa KhalidPathology, University of Health Sciences Lahore, Lahore, PAK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOral cancer ranks as one of the most prevalent malignancies worldwide. While the role of B-cell lymphoma 3 ( METHODOLOGY: A cross-sectional evaluation based on a case-control study was conducted from September 2022 to January 2023, enrolling 100 participants, of whom 77 were patients diagnosed with OC and 23 were healthy control participants. Two subtypes, squamous cell carcinoma (SCC) and mucoepidermoid carcinoma (MEC), were examined. RNA was drawn from both tissue and peripheral blood samples using the QIAamp Blood RNA Kit (#51104, Qiagen, Hilden, Germany). Subsequently, RESULTS AND

conclusionThe highest

Indexed as

bcl3mucoepidermoid carcinomaoral canceroral carcinomasquamous cell carcinoma

Identifiers

PMID40486320
PMCPMC12143743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.